π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Dementia with Lewy Body (DLB) is a common neurodegenerative disorder respon...
Status
Unknown
Location
Multiple Locations
Start Date
2019-12-14
Trial ID
NCT04154215
Treatments Being Tested
Randomized phase I trial to compare the effectiveness of two different vacc...
Status
Terminated
Location
Mount Sinai Medical Center
Start Date
2001-12
Trial ID
NCT00030693
This phase II trial is studying how well thalidomide works in treating pati...
Status
Completed
Location
Gynecologic Oncology Group
Start Date
2001-09
Trial ID
NCT00025506
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
This phase I/II clinical trial is studying the side effects and best dose o...
Status
Terminated
Location
Lucile Packard Children's Hospital Stanford University
Start Date
2010-03
Trial ID
NCT01088763
Imatinib mesylate may stop the growth of tumor cells by blocking the enzyme...
Status
Terminated
Location
Cancer and Leukemia Group B
Start Date
2002-06
Trial ID
NCT00042952
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of melphalan w...
Status
Completed
Location
University of Minnesota/Masonic Cancer Center
Start Date
2005-09-15
Trial ID
NCT00303849
The purpose of this post-marketing study is to evaluate the efficacy, immun...
Status
Completed
Location
Songzi Center for Disease Control and Prevention
Start Date
2019-03-26
Trial ID
NCT03903926
Treatments Being Tested
This research trial studies gene expression in patients with prostate cance...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2013-05-30
Trial ID
NCT01953640
Treatments Being Tested
The GLUREDIA study investigates the counter-regulatory response (CRR) durin...
Status
Recruiting
Location
Clinique Universitaires Saint Luc
Start Date
2022-05-25
Trial ID
NCT06770621